David Rice
Plus aucun poste en cours
Profil
David Rice worked as a Senior Director of Government Relations at Mylan, Inc. and as a Chief Compliance Officer at GSC Investment Corp.
He holds a graduate degree from Yale University, a doctorate from the University of California, Berkeley, and an undergraduate degree from the University of California, Davis.
Anciens postes connus de David Rice
| Sociétés | Poste | Fin |
|---|---|---|
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Conseiller Juridique Général | - |
GSC Investment Corp. /Old/
 GSC Investment Corp. /Old/ Financial ConglomeratesFinance GSC Investment LLC provides investment services. It is a closed-end management investment company. The company's investment objectives are to generate both current income and capital appreciation through debt and to a lesser extent, equity investments by primarily investing in private middle market companies. The company was founded on March 21, 2007 and is headquartered in New York, NY. | Compliance Officer | - |
Formation de David Rice
| University of California, Berkeley | Doctorate Degree |
| University of California, Davis | Undergraduate Degree |
| Yale University | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
GSC Investment Corp. /Old/
GSC Investment Corp. /Old/ Financial ConglomeratesFinance GSC Investment LLC provides investment services. It is a closed-end management investment company. The company's investment objectives are to generate both current income and capital appreciation through debt and to a lesser extent, equity investments by primarily investing in private middle market companies. The company was founded on March 21, 2007 and is headquartered in New York, NY. | Finance |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
